`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALSINC., TEVA PHARMACEUTICALS USA,
`INC., and AKORN INC.,'
`Petitioners,
`
`Vv.
`
`ALLERGAN,INC.,
`Patent Owner.
`
`Case IPR2016-01127 (8,685,930 B2)
`Case IPR2016-01128 (8,629,111 B2)
`Case IPR2016-01129 (8,642,556 B2)
`Case IPR2016-01130 (8,633,162 B2)
`Case IPR2016-01131 (8,648,048 B2)
`Case IPR2016-01132 (9,248,191 B2)
`
`DECLARATION OF MARSHAK SCHMIDT IN SUPPORT OF
`PATENT OWNER’S MOTIONFOR PRO HAC VICE ADMISSION OF
`MARSHAK SCHMIDT UNDER37 C.F.R.§ 42.10(c)
`
`' Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017- 00596,
`IPR2017-00579 and IPR2017-00598, IPR2017-00583 and IPR2017- 00599,
`IPR2017-00585 and IPR2017-00600, and IPR2017-00586 and IPR2017-00601, have
`respectively been joined with the captioned proceedings. The word-for-word
`identical paperis filed in each proceeding identified in the caption pursuantto the
`Board’s Scheduling Order (Paper 10).
`
`SRMT2104 - Page 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`SRMT 2104 - Page 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`
`
`I, MARSHAK SCHMIDT,declareas follows:
`
`1. lam more than twenty-one years of age, competentto presentthis affidavit, and
`
`have personal knowledgeofthe facts set forth herein.
`
`2. This affidavit is given in support of Patent Owner’s Motion for Pro Hac Vice
`
`Admission of Marsha K. Schmidt.
`
`3. Ihavebeen practicing law since 1984 and have extensive experience litigating
`
`cases involving Indian law in manydifferent courts across the United States., as well
`
`as federal administrative boards.
`
`4.1 am a memberin good standing ofthe District of Columbia Bar, as well as the
`
`following Federal Courts: the U.S. Supreme Court, the United States Court of
`
`Appeals for the SecondCircuit, U.S. District Court for the District of Columbia, U.S.
`
`District Court for the Northern District of New York, the United States Court of
`
`Appeals for the Federal Circuit, and the U.S. Court of Federal Claims.
`
`5. | have never been suspendedordisbarred from practice before any court or
`
`administrative body.
`
`6. No court or administrative body has ever denied my application for admission
`
`to practice beforeit.
`
`7. No court or administrative body has imposed sanctions or contemptcitations on
`
`me.
`
`SRMT2104 - Page 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`SRMT 2104 - Page 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`
`
`8. | have read and will comply with the Office Patent Trial Practice Guide and the
`
`Board’s Rules of Practice for Trials set forth in in 37 C.F.R. § 42.
`
`9. | understandthat I will be subject to the USPTO Codeof Professional
`
`Responsibility set forth in 37 C.F.R. §§ 10.20 et seq. and disciplinary jurisdiction
`
`under 37 C.F.R. § 11.19(a).
`
`10. I have not applied to appear pro hacvice in any other proceedings before the
`
`Office in the last three years.
`
`11. I currently represent Patent Owner, Saint Regis MohawkTribe,in other cases,
`
`and I have an expertise in Indian law andtribal sovereign immunity, which is an
`
`issue in this proceeding.
`
`12. I have also represented manyothertribes over the course of my career and
`
`have extensive knowledgeoftribes as sovereigns.
`
`13. I hereby declare that all statements made herein of my own knowledgeare true
`
`and further that all statements herein are made with knowledgethatwillful false
`
`statements and the like are punishable by fine or imprisonment, or both, under
`
`Dated: September 11, 2017
`
`Attorney at Law
`14928 Perrywood Drive
`Burtonsville, MD 20866
`301-949-5176
`marsha@mkschmidtlaw.com
`
`
`
`SRMT2104 - Page 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`SRMT 2104 - Page 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`